3 edition of BIOSPECIFICS TECHNOLOGIES CORP. found in the catalog.
BIOSPECIFICS TECHNOLOGIES CORP.
ICON Group Ltd.
April 25, 2000
by Icon Group International
Written in English
|The Physical Object|
|Number of Pages||21|
Latest Biospecifics Technologies Corp (BSTC:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. WILMINGTON, Del., /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with.
BioSpecifics Technologies Corp. is a biopharmaceutical company which is engaged in the development of an injectable collagenase for multiple indications. BioSpecifics Technologies Corp. (BSTC) Related Stocks - discover similar stocks, compare dividends and return. Compare momentum and price performance.
WILMINGTON, Del., April 9, /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies. BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX.
Three-C site, an early Pueblo II ruin in Chaco Canyon, New Mexico
true story of Jumbo, the elephant.
Interviewing and investigating
The psychology of attitudes and attitude change
Bringing it together
The cloud of unknowing
State-purchase of railways
Meaning and English grammar
Captain Foulenough & company
arts we see
Price Book Value is a widely used stock evaluation measure. Find the latest Price Book Value for BioSpecifics Technologies Corp (BSTC). Book Value (Per Share) is a widely used stock evaluation measure.
Find the latest Book Value (Per Share) for BioSpecifics Technologies Corp (BSTC). Historical price to book ratio values for BioSpecifics Technologies Corp (BSTC) over the last 10 years.
The current price to book ratio for BioSpecifics Technologies Corp. BioSpecifics Technologies Corp book value per share from to Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis.
Compare BSTC With Other Stocks BioSpecifics Technologies Corp Book Value Per Share Historical Data. BioSpecifics Technologies Corp. company facts, information and stock details by MarketWatch.
View bstc business summary and other industry information. In depth view into BioSpecifics Technologies Price to Book Value including historical data fromcharts, stats and industry comps.
BioSpecifics Technologies Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View BSTC financial statements in ees: 7. BioSpecifics Technologies Corp. annual cash flow and in depth look at BSTC operating, investing, and financing activities.
Biospecifics Technologies Corp. reported assets of about $ million as of Sept. 30, and operating revenue of more than $19 million through the first three quarters of Its stock, traded as BSTC, fell about % to $ a share following the news of the move.
By Jacob Owens [email protected]. In the last year BioSpecifics Technologies insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by individuals) over.
Stock analysis for BioSpecifics Technologies Corp (BSTC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company ees: 7. Find the latest BioSpecifics Technologies Corp (BSTC) stock quote, history, news and other vital information to help you with your stock trading and investing.
BioSpecifics Technologies's current price is $ Its book value per share for the quarter that ended in Mar. was $ Hence, today's PB Ratio of BioSpecifics Technologies is During the past 13 years, the highest P/B Ratio of BioSpecifics Technologies was The lowest was And the median was In-depth view of key statistics and finances for BIOSPECIFICS TECHNOLOGIES CORP.
(BSTC) on MSN Money. msn back to msn home money. powered by Price/Book Value. Price/Cash flow. Business Summary: BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for various indications in the United States and internationally.
The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's. The P/E ratio of BioSpecifics Technologies iswhich means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about Price to Book Value per Share Ratio.
BioSpecifics Technologies has a P/B Ratio of BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a. Description: BioSpecifics Technologies Corp is a biopharmaceutical company that specializes in collagenase for multiple indications.
Injectable collagenase is marketed in various geographic regions, including the U.S., the EU, and Australia, under the Xiaflex name. BioSpecifics Technologies Corp (NASDAQ: BSTC) stock closed at per share at the end of the most recent trading day (a % change compared to the prior day closing price) with a volume of K shares and market capitalization of a component of indices and it is traded on NASDAQ exchange.
The company belongs in the Biotechnology industry. BioSpecifics Technologies Corp. registration SEC filings breakout by MarketWatch. View the BSTC report for the company's profitability and securities offered by date.
WILMINGTON, Del., J /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC) (the "Company"), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX ® in North America, today announced the appointment of Alex Monteith as Senior.
Book To Share Value – The book to share value ratio compares the the share price to the book value of assets owned by the company. as it relates to BioSpecifics Technologies Corp., the book to share value ratio comes in at BIOSPECIFICS TECHNOLOGIES CORP.
BioSpecifics Technologies Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows: 1.
The name of this corporation is BioSpecifics Technologies Corp. (the “Corporation”).